Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTAW) Long-Term Investments (2019 - 2023)

Historic Long-Term Investments for Strata Critical Medical (SRTAW) over the last 5 years, with Q3 2023 value amounting to $390000.0.

  • Strata Critical Medical's Long-Term Investments changed 0.0% to $390000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $390000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $390000.0 for FY2022, which is N/A changed from last year.
  • Per Strata Critical Medical's latest filing, its Long-Term Investments stood at $390000.0 for Q3 2023, which was down 0.0% from $390000.0 recorded in Q2 2023.
  • Strata Critical Medical's Long-Term Investments' 5-year high stood at $277.2 million during Q2 2020, with a 5-year trough of $200000.0 in Q3 2020.
  • In the last 5 years, Strata Critical Medical's Long-Term Investments had a median value of $390000.0 in 2022 and averaged $97.8 million.
  • In the last 5 years, Strata Critical Medical's Long-Term Investments plummeted by 9992.79% in 2021 and then soared by 9500.0% in 2022.
  • Over the past 5 years, Strata Critical Medical's Long-Term Investments (Quarter) stood at $276.3 million in 2019, then rose by 0.25% to $276.9 million in 2020, then crashed by 99.93% to $200000.0 in 2021, then surged by 95.0% to $390000.0 in 2022, then changed by 0.0% to $390000.0 in 2023.
  • Its Long-Term Investments stands at $390000.0 for Q3 2023, versus $390000.0 for Q2 2023 and $390000.0 for Q1 2023.